Protein 2.1 is a 210-kilodalton protein that connects erythrocyte spectrin to the NH2-terminal cytoplasmic domain of band 3 and thereby functions as the essential linkage between the membrane skeleton and the bilayer. We cleaved this protein into specific chemical domains by limited digestion with trypsin and a-chymotrypsin at 0C. Intermediate-sized peptides were separated by two-dimensional isoelectric focusing/NaDodSO4/polyacrylamide gel electrophoresis and characterized by high resolution peptide mapping. We have established a provisional structural model of protein 2
and characterized by high resolution peptide mapping. We have established a provisional structural model of protein 2.1 by comparing the peptide maps of these chemical domains to maps obtained from larger overlapping chymotryptic fragments as well as fragments obtained from 2-nitro-5-thiocyanobenzoic acid cleavage. In addition to providing a provisional structural map of protein 2.1, we have identified two functional domains of protein 2.1, an 83-kilodalton tryptic peptide (T-83) which binds band 3 and a 65-kilodalton tryptic peptide (T-65) which binds spectrin. We have therefore localized the functional domains along our linear map of protein 2.1.
Erythrocyte membrane proteins 2.1, 2.2, 2.3, and 2.6 [referred to by the nomenclature of Steck (1); also termed syndeins] are a family of sequence-related phosphoproteins ranging in molecular mass from 150 to 210 kilodaltons (kDa), which are peripherally associated with the cytoplasmic surface of the plasma membrane (for reviews, see refs. 1 and 2). The progenitor polypeptide protein 2.1 (also termed ankyrin) is converted into the other family members by a cascade of proteolytic events that occur on the cytoplasmic membrane surface (3) . The syndeins bind spectrin to the membrane (2) by associating with the 13 subunit of spectrin tetramers (4) -200 A from the junctional ends of the heterodimers (5) . The stoichiometry in situ is one syndein bound per spectrin (at3)2 tetramer (6) . The syndeins in turn are associated with the NH2-terminal cytoplasmic domain of the integral membrane glycoprotein band 3 (7, 8) . Therefore, the syndeins function in linking the membrane skeleton to the bilayer by linking spectrin to band 3.
Protein 2.1 can be isolated free of proteins 2.2 to 2.6 and other erythrocyte membrane proteins by high-salt extraction of spectrin-depleted inverted vesicles, followed by ion-exchange chromatography (5) . In this report, we describe the identification of chemical domains within protein 2.1 defined by limited proteolytic digestion at 0C. The linear alignment of these fragments along the protein 2.1 molecule has been determined by high resolution two-dimensional peptide mapping of overlapping peptides obtained by proteolytic or chemical cleavage. We have also identified the domains of protein 2.1 involved in binding band 3 and spectrin.
MATERIALS AND METHODS
Purification of Protein 2.1. Purification of protein 2.1 from human erythrocyte membranes was carried out as described (8) . The purified protein was stored frozen at -20'C in 5 mM sodium phosphate/0.2 M KCI/1 mM EDTA, pH 7.6 .
Gel Electrophoresis. One-dimensional NaDodSO4/PAGE was performed in 10% polyacrylamide slab gels by the discontinuous system of Laemmli (9) . Gels containing linear gradients of acrylamide had gradients ranging from 10% to 15%. Two-dimensional PAGE was carried out according to a modification of the O'Farrell method (10) . Isoelectric focusing (IEF) gels (100 mm in length) were prepared in glass tubes [125 x 5.0 mm (inside diameter)] as follows. Nine grams of ultrapure urea (Schwarz/Mann) and 0.15 grams of Triton X-100 (Sigma) were dissolved at 370C in 29.1% acrylamide/0.9% methylenebisacrylamide, 2.5 ml each, diluted with H20 to a total volume of 14 ml. Amberlite MB-3 (2 g; Sigma) was added to the solution, which successively was stirred at room temperature for 15 min. The ion exchanger was removed by filtration on a MILLEX-HA 0.45-/im filter (Millipore). Ampholines (250 ,l each; Pharmacia) covering the pH ranges pH 5-7, pH 3.5-10, and pH 4-6, and 225 ,l of 0.004% riboflavin (Sigma) were added to the filtered solution. Gel solutions were overlayed with 100 Al of 8 M urea and polymerized under light for 4 hr. The top of the gels were rinsed with 100 A.l of sample buffer [9.5 M urea/2% (wt/vol) Triton X-100/1% dithiothreitol, and 0.8% each of Ampholines of pH 5-7, pH 3.5-10, and pH [4] [5] [6] . Lyophilized saltfree samples were dissolved in 100 A.l of the sample buffer and loaded on the gels. The samples were overlayed with 100
A.l of sample buffer diluted 8:2 with water. Focusing was carried out at room temperature for 16 hr at 350 V with 0.1 M H3PO4 and 0.02 M NaOH as electrode buffers. Gels were removed from the glass tubes with 8 M urea and equilibrated 30 min in the equilibration buffer (3% NaDodSO4/4 mM EDTA/10% glycerol/1% dithiothreitol/0.01% bromphenol blue). Gels were cemented to the top of 10-15% gradient polyacrylamide slab gels with 1% agarose (Bio-Rad) dissolved in the equilibration buffer. Electrophoresis in the second dimension was carried out at a constant current of 25 mA per gel. All NaDodSO4/polyacrylamide gels wcre stained and destained as described by Fairbanks et al. (11) .
Analytical IEF. IEF was carried out in Ampholine polyacrylamide gel plates, pH 3.5-9.5 (LKB). Proteins were focused at 10'C for 2 hr at a constant power of 3 W. Focused proteins were fixed and stained according to the LKB IEF instruction manual (LKB). Isoelectric points were determined using an IEF pl calibration kit containing proteins that covered the pl range 2.5-10.5 (Pharmacia).
Abbreviations: IEF, isoelectric focusing; kDa, kilodalton; NTCB, 2-nitro-5-thiocyanobenzoic acid.
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Restricted Proteolytic Digestion of Protein 2.1. Purified protein 2.1 was dialyzed into 0.02 M NH4HCO3 (pH 8.0) and digested at 0°C with either trypsin (Sigma) or a-chymotrypsin (Sigma) in a substrate-to-enzyme ratio of 20:1. Proteolysis was either stopped by freezing the digest in liquid N2 with subsequent lyophilization or by adding 3 mM diisopropyl fluorophosphate (Sigma). When required, solutions with protein 2.1 were concentrated on a Diaflo ultrafiltration membrane PM10 (Amicon) prior to digestion.
Hydrolysis at Cysteine Residues. Lyophilized protein 2.1 was dissolved in 0.2 M Tris HCl/7 M guanidine-HCl/1 mM EDTA, pH 8.0. Cleavage of the polypeptide chain at cysteine residues with 2-nitro-5-thiocyanobenzoic acid (NTCB) (Sigma) was carried out as described by Speicher et al. (12) . Prior to two-dimensional IEF/PAGE, samples were dialyzed against 0.01 M NH4HCO3 and lyophilized.
Two-Dimensional Peptide Mapping Analysis. Polypeptides separated in two-dimensional IEF/NaDodSO4/polyacrylamide gels were cut from the gel and radiolabeled with 1251 directly within the gel slices by the method of Elder et al. (13) . After extensive washing, the proteins in the gel slices were digested with 25 ,g of trypsin in 0. Fractions covering peak C were pooled and separated at 4°C on a Bio-Gel P-4 column (2.7 x 15 cm) equilibrated in 0.1 M sodium acetate buffer, pH 5.3. The void volume fraction was collected and loaded directly onto a Whatman CM 52 cation exchanger (0.9 x 9 cm) equilibrated with the acetate buffer. The acidic fragment, which was not retained by the column resin, was collected in the unretarded fraction eluting from the ion-exchange column with the acetate buffer. The fragment was transferred into 0.01 M NH4HCO3 by gel filtration on Bio-Gel P-4 and subsequently concentrated by lyophilization.
Binding Assays. Inhibition by protein 2.1 fragments of spectrin binding to spectrin-depleted inside-out vesicles was measured by using the assay system described by Goodman and Weidner (6) Fig. 2 A and B) . In order to trap the C-175 a-chymotryptic fragment in high enough concentration for peptide mapping analysis, the gel was intentionally overloaded with protein from the a-chymotryptic digest. The tryptic fragments T-83, T-65, and T-11 appeared in the second dimension as shown in Fig. 2A . The small T-11 fragment moved just behind the tracking dye and focused with an apparent pI of 4.8 near the acidic end of the urea gel. The T-83 and T-65 protein fragments focused in the urea gel as multiple spots with minor differences in isoelectric points. The T-83 and the T-65 fragments focused in the apparent pI ranges 7.5-8.0 and 6.2-6.8, respectively. Two-dimensional PAGE of the overloaded a-chymotryptic fragments is shown in Fig.  2B . The fragments C-83 and C-72 also focused as arrays of spots in the same apparent pI ranges as observed for the large tryptic fragments. The intermediate fragment C-175 appeared in much smaller concentration than did C-83 and C-72. The NTCB cleavage products of protein 2.1 also were separated by two-dimensional IEF/PAGE (data not shown) for use in peptide mapping studies.
Peptide Mapping Analysis of Protein 2.1 Fragments. The individual Coomassie-stained fragments in an array of spots differing only in isoelectric point were found to have identical peptide maps (data not shown). This applied to all protein 2.1 fragments studied; therefore, the center portion of every array was cut from the gel and used to represent the various fragments. In order to sequentially align the fragments in protein 2.1, peptide maps of T-83, T-65, T-11, C-175, C-83, and C-72 were utilized. In addition, two overlapping fragments that were obtained from NTCB cleavage of protein 2.1 were used. These fragments had molecular masses of 85 kDa (NTCB-85) and 80 kDa (NTCB-80), respectively. The peptide maps of the three major tryptic fragments are shown in Fig. 3 . They comprise 76% of the molecular mass of protein Fig. 2A) were 1251-radiolabeled and analyzed by peptide mapping as described.
2.1. Peptide maps of T-83 (Fig. 3) and C-83 (not shown) were nearly identical. Thus, at 0°C, trypsin and a-chymotrypsin appear to release similar 83-kDa fragments from protein 2.1. Because of the different substrate specificities of trypsin and a-chymotrypsin, some differences between C-83 and T-83 would be expected; however, the small regions that differ might contain few iodinatable tyrosine residues. The peptide map of C-72 (not shown) contained the entire map of T-65 (Fig. 3) . Three extra spots were found on the C-72 map, which must represent the extra polypeptide (7 kDa) missing in the T-65 fragment.
Fragments overlapping the tryptic fragments are C-175, NTCB-85, and NTCB-80. Their respective peptide maps and the map of 2.1 are shown in Fig. 4 . The map of C-175 contains the entire maps of T-83 and T-65. However, a few additional spots are present on the C-175 map. These spots must come from a 27-kDa polypeptide segment that is not a part of either T-83 or T-65. The map of C-175 presents evidence that T-83 and T-65 are either adjacent or maximally separated by a region of 27 kDa. The map of NTCB-80 shows that T-83 and T-65 are probably not adjacent because 60% of the NTCB-80 map is found on the T-83 map and only 30% of the T-65 map. The remaining 10% of the spots must be derived from the polypeptide region separating T-83 and T-65, or represent the new terminal ends of NTCB-80. Three of these additional spots on the NTCB-80 map are found among the spots on the C-175 map that could not be seen on the T-83 and T-65 maps. The C-175 map also contains three other extra spots (shown with arrows in Fig. 4 ) not found in the T-83, T-65, or NTCB-80 maps, which however correspond to the three extra spots on the C-72 map when this map is compared to the T-65 map.
It is concluded that T-83 and T-65 are separated by a polypeptide piece of molecular mass < 27 kDa and that C-72 extends closer to a chemical end of protein 2.1 than does T-65. C-175 does not contain any of the limit fragments found on the map of the acidic T-11 fragment. Therefore, T-11 must be within 35 kDa of an end of the protein. The map of NTCB-85 had no spots in common with the T-65 fragment, but 23% of the spots are found on the map of T-83. Thus, the NTCB-85 fragment overlaps the T-83 fragment and, in addition, contains the remaining polypeptide piece that together with the C-175 fragment constitutes the entire protein 2.1 molecule. The entire map of the acidic fragment T-11 is found in the NTCB-85 map. This is consistent with the observation that NTCB-85 in two-dimensional PAGE focused as an acidic fragment in the apparent pH range 5.4-5.6 and places T-11 on the opposite end of the molecule from T-65 (or C-72). Therefore, the consecutive order of the tryptic fragments is T-11, T-83, and T-65. T-11 and T-83 are separated by a protease-sensitive region that can be found in the NTCB-85 fragment, and T-83 and T-65 are separated by another protease-sensitive region that can be found in the NTCB-80 fragment. Purification of Tryptic Fragments. Gel filtration on Sephacryl S-200 of a tryptic digest of purified protein 2.1 (6.3 mg) resulted in three protein peaks (Fig. 5) . The elution profile is consistent with the electrophoretic picture of the digest seen after NaDodSO4/PAGE, which revealed three fragments in (Fig. 1A) . NaDodSO4/PAGE of protein from peaks A and B confirmed that the fragments T-83 and T-65 were present in these peaks, respectively (Fig. 5 Inset) . The recovery of T-83 and T-65 from this gel filtration column was 90% and 75%, respectively. Peak C contained the acidic fragment T-11, which migrated just behind the tracking dye on NaDodSO4/PAGE (10% polyacrylamide) (Fig. 5 Inset) . By utilizing the acidic properties of the T-11 fragment, the fragment could be purified free from other small degradation products by simply eluting the fragment through a Whatman CM 52 cation-exchange column in 0.1 M sodium acetate (pH 5.3 Fig. 5 . The T-83 fragment clearly inhibited binding of protein 2.1 to band 3. The most concentrated fraction from peak A resulted in 94% inhibition. The T-83 fragment did not inhibit protein 2.1 binding to spectrin. This binding was found to be inhibited by the T-65 fragment. The greatest inhibition measured in fractions from peak B was 40%. The acidic fragment T-11 had no effect in either of the two assay systems. Thus, the binding sites for band 3 and spectrin in protein 2.1 are localized in the tryptic fragments T-83 and T-65, respectively.
DISCUSSION
Three intermediate-size tryptic peptides (T-83, T-65, and T-11) and two chymotryptic peptides (C-83 and C-72) of protein 2.1 are relatively resistant to further proteolytic digestion under our conditions. These chemical domains have been aligned into the structural model presented in Fig. 7 , based upon our peptide mapping analysis of each domain and several larger overlapping fragments (C-175, NTCB-80, and NTCB-85). The acidic T-11 fragment must be within 35 kDa of one end, as it is not a portion of the C-175 overlapping fragment. The T-65 fragment must be toward the other end of the molecule, as it does not overlap the NTCB-85 acidic fragment, which contains the entire T-11 fragment-a unique protease-sensitive region not found in the tryptic fragments-and a portion of the T-83 fragment. The NTCB-80 fragment overlaps a portion of both the T-83 and T-65 fragments in addition to a protease-sensitive region that separates these tryptic peptides. All of the limit peptides found on the high-resolution peptide map of protein 2.1 can be accounted for on the maps of the fragments presented in Fig. 7 (14) , and this 72-kDa fragment was used to identify the syndeins or ankyrin as the spectrin-binding proteins (15, 16) . Apparently this historically important 72-kDa fragment and C-72 are identical spectrin-binding domains of protein 2.1.
